Patents by Inventor Benjamin Rubin
Benjamin Rubin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240082177Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.Type: ApplicationFiled: November 10, 2023Publication date: March 14, 2024Applicants: MESHABERASE, LLC, The United States of America, as Represented by the Secretary, Department of Health & Human ServicesInventors: Benjamin Rubin, Mark Gilbert, Jinkyu Jung
-
Publication number: 20240072456Abstract: Antenna-plexers for interference cancellation are provided herein. In certain embodiments, a wireless device includes an antenna, an antenna-plexer coupled to the antenna and configured to generate a feedback signal, a transmitter configured to transmit a transmit signal to the antenna by way of the antenna-plexer, a receiver configured to process a receive signal, and a feedback receiver configured to process the feedback signal from the antenna-plexer to provide compensation to the receive signal.Type: ApplicationFiled: September 7, 2023Publication date: February 29, 2024Inventors: David Richard Pehlke, Anand Raghavan, Poul Olesen, Werner Schelmbauer, Thorsten Tracht, Wolfgang Thomann, Amir Israel Rubin, Assi Jakoby, Ofer Benjamin
-
Publication number: 20240070270Abstract: A computer-implemented method of generating a security language query from a user input query includes receiving, at a computer system, an input security hunting user query indicating a user intention; selecting, using a trained machine learning model and based on the input security hunting query, an example user security hunting query and corresponding example security language query; generating, using the trained machine learning model, query metadata from the input security hunting query; generating a prompt, the prompt comprising: the input security hunting user query; the selected example user security hunting query and the corresponding example security language query; and the generated query metadata; inputting the prompt to a large language model; receiving a security language query from the large language model corresponding to the input security hunting query reflective of the user intention.Type: ApplicationFiled: August 31, 2022Publication date: February 29, 2024Inventors: Daniel Lee MACE, William BLUM, Jeremias EICHELBAUM, Amir RUBIN, Edir V. GARCIA LAZO, Nihal Irmak PAKIS, Yogesh K. ROY, Jugal PARIKH, Peter A. BRYAN, Benjamin Elliott NICK, Ram Shankar Siva KUMAR
-
Patent number: 11844769Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.Type: GrantFiled: June 2, 2021Date of Patent: December 19, 2023Assignees: MESHABERASE, LLC, The United States of America, as Represented by the Secretary, Department of Health and Human ServicesInventors: Benjamin Rubin, Mark Gilbert, Jinkyu Jung
-
Publication number: 20220346694Abstract: Systems and methods are provided for a multi-modal sleep system comprising a data processor for operating in a plurality of operating modes. The data processor may detect at least one sensor providing data to the data processor and determine a sensor type associated with each of the at least one sensor. The data processor may select a mode of operation based on the determined sensor type of the detected at least one sensor and of each of the at least one sensor. A first of the plurality of operating modes may be selected in response to determining that the at least one detected sensor includes a first sensor type or combination of sensor types. The data processor may be configured to receive data from the at least one detected sensor and process the received data according to the selected mode of operation to output a characterization of a user's sleep.Type: ApplicationFiled: July 15, 2022Publication date: November 3, 2022Applicant: ResMed Sensor Technologies Limited.Inventor: Benjamin RUBIN
-
Publication number: 20210290569Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.Type: ApplicationFiled: June 2, 2021Publication date: September 23, 2021Applicants: MESHABERASE, LLC, United States Department of Health and Human Services, National Institutes of HealthInventors: Benjamin Rubin, Mark Gilbert, Jinkyu Jung
-
Publication number: 20210267529Abstract: Systems and methods are provided for a multi-modal sleep system comprising a data processor for operating in a plurality of operating modes. The data processor may detect at least one sensor providing data to the data processor and determine a sensor type associated with each of the at least one sensor. The data processor may select a mode of operation based on the determined sensor type of the detected at least one sensor and of each of the at least one sensor. A first of the plurality of operating modes may be selected in response to determining that the at least one detected sensor includes a first sensor type or combination of sensor types. The data processor may be configured to receive data from the at least one detected sensor and process the received data according to the selected mode of operation to output a characterization of a user's sleep.Type: ApplicationFiled: January 19, 2021Publication date: September 2, 2021Applicant: Resmed Sensor Technologies LimitedInventor: Benjamin RUBIN
-
Patent number: 11052057Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.Type: GrantFiled: October 7, 2019Date of Patent: July 6, 2021Assignees: MESHABERASE, LLC, The United States of America, as Represented by the Secretary, Dept of Health and Human ServicesInventors: Benjamin Rubin, Raj Puri, Bharat Joshi
-
Publication number: 20210196652Abstract: Methods for treating or inhibiting dysfunctional tear syndrome (DTS) or symptoms associated therewith, and compositions for use in the methods.Type: ApplicationFiled: December 11, 2020Publication date: July 1, 2021Applicant: MESHABERASE, LLCInventor: Benjamin RUBIN
-
Publication number: 20210082305Abstract: System and method for a user to monitor and/or modify his or her sleep. In one embodiment, the sleep coaching system comprises a sensor for sensing a physiological signal of a sleeping user such as an EEG, computer memory databases for storing user and sleep-related data and advice, and a processor that generates a set of advice to improve user sleep satisfaction based on the user and sleep-related data. The advice to improve user sleep satisfaction, which may be communicated to the user, may comprise a sleep coaching plan, which may include one or more sleep coaching workshops that the user may undertake.Type: ApplicationFiled: August 27, 2020Publication date: March 18, 2021Applicant: RESMED SENSOR TECHNOLOGIES LIMITEDInventors: David DICKINSON, Jason DONAHUE, Stephan FABREGAS, Benjamin RUBIN, John SHAMBROOM, Eric SHASHOUA
-
Publication number: 20200147010Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.Type: ApplicationFiled: October 7, 2019Publication date: May 14, 2020Applicants: MESHABERASE, LLC, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICESInventors: Benjamin RUBIN, Raj PURI, Bharat JOSHI
-
Publication number: 20190142769Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.Type: ApplicationFiled: January 10, 2019Publication date: May 16, 2019Applicants: MESHABERASE, LLC, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICESInventors: Benjamin RUBIN, Raj PURI, Bharat JOSHI
-
Publication number: 20180042870Abstract: The present disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or derivatives thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.Type: ApplicationFiled: September 8, 2017Publication date: February 15, 2018Applicant: Meshaberase, LLCInventors: Benjamin RUBIN, Raj PURI, Bharat JOSHI
-
Publication number: 20160184242Abstract: The present disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or derivatives thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.Type: ApplicationFiled: March 9, 2016Publication date: June 30, 2016Inventors: Raj K. Puri, Bharat H. Joshi, Benjamin Rubin
-
Publication number: 20150051453Abstract: Systems and methods are provided for a multi-modal sleep system comprising a data processor for operating in a plurality of operating modes. The data processor may detect at least one sensor providing data to the data processor and determine a sensor type associated with each of the at least one sensor. The data processor may select a mode of operation based on the determined sensor type of the detected at least one sensor and of each of the at least one sensor. A first of the plurality of operating modes may be selected in response to determining that the at least one detected sensor includes a first sensor type or combination of sensor types. The data processor may be configured to receive data from the at least one detected sensor and process the received data according to the selected mode of operation to output a characterization of a user's sleep.Type: ApplicationFiled: September 26, 2014Publication date: February 19, 2015Inventor: Benjamin Rubin
-
Patent number: 8870764Abstract: Systems and methods are provided for a multi-modal sleep system comprising a data processor for operating in a plurality of operating modes. The data processor may detect at least one sensor providing data to the data processor and determine a sensor type associated with each of the at least one sensor. The data processor may select a mode of operation based on the determined sensor type of the detected at least one sensor and of each of the at least one sensor. A first of the plurality of operating modes may be selected in response to determining that the at least one detected sensor includes a first sensor type or combination of sensor types. The data processor may be configured to receive data from the at least one detected sensor and process the received data according to the selected mode of operation to output a characterization of a user's sleep.Type: GrantFiled: September 6, 2011Date of Patent: October 28, 2014Assignee: ResMed Sensor Technologies LimitedInventor: Benjamin Rubin
-
Publication number: 20140314841Abstract: The present disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or derivatives thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.Type: ApplicationFiled: April 18, 2014Publication date: October 23, 2014Applicant: The United States of America, as Represented by the Secretary, Department of Health and Human ServInventors: Raj K. Puri, Bharat H. Joshi, Benjamin Rubin
-
Publication number: 20130344465Abstract: System and method for a user to monitor and/or modify his or her sleep. In one embodiment, the sleep coaching system comprises a sensor for sensing a physiological signal of a sleeping user such as an EEG, computer memory databases for storing user and sleep-related data and advice, and a processor that generates a set of advice to improve user sleep satisfaction based on the user and sleep-related data. The advice to improve user sleep satisfaction, which may be communicated to the user, may comprise a sleep coaching plan, which may include one or more sleep coaching workshops that the user may undertake.Type: ApplicationFiled: August 23, 2013Publication date: December 26, 2013Applicant: ResMed Sensor Technologies LimitedInventors: David Dickinson, Jason Donahue, Stephen Fabregas, Benjamin Rubin, John Shambroom, Eric Shashoua
-
Publication number: 20130060097Abstract: Systems and methods are provided for a multi-modal sleep system comprising a data processor for operating in a plurality of operating modes. The data processor may detect at least one sensor providing data to the data processor and determine a sensor type associated with each of the at least one sensor. The data processor may select a mode of operation based on the determined sensor type of the detected at least one sensor and of each of the at least one sensor. A first of the plurality of operating modes may be selected in response to determining that the at least one detected sensor includes a first sensor type or combination of sensor types. The data processor may be configured to receive data from the at least one detected sensor and process the received data according to the selected mode of operation to output a characterization of a user's sleep.Type: ApplicationFiled: September 6, 2011Publication date: March 7, 2013Applicant: Zeo, Inc.Inventor: Benjamin Rubin
-
Publication number: 20100099954Abstract: System and method for a user to monitor and/or modify his or her sleep. In one embodiment, the sleep coaching system comprises a sensor for sensing a physiological signal of a sleeping user such as an EEG, computer memory databases for storing user and sleep-related data and advice, and a processor that generates a set of advice to improve user sleep satisfaction based on the user and sleep-related data. The advice to improve user sleep satisfaction, which may be communicated to the user, may comprise a sleep coaching plan, which may include one or more sleep coaching workshops that the user may undertake.Type: ApplicationFiled: May 6, 2009Publication date: April 22, 2010Applicant: Zeo, Inc.Inventors: David Dickinson, Jason Donahue, Stephen Fabregas, Benjamin Rubin, John Shambroom, Eric Shashoua